Dr. Kimberly Hodge-Bell is a Senior Fellow and leads the Macromolecule Toxicology Team at Bayer Crop Science in St. Louis, Missouri. In this position, she provides toxicology support regarding scientific human health risk assessment principles for new and existing products to inform business decisions and enable successful product registration and commercialization globally. She is a strategic scientific leader with a career focused on the toxicological weight of evidence risk assessment and risk-based defense.
A native of the Bronx, New York, Dr. Hodge-Bell is a graduate of Virginia Union University in Richmond, VA (Bachelor of Science in Biology), earned a doctorate in Biomedical Science (concentration in Pharmacology and Toxicology) from Meharry Medical College in Nashville, TN and completed her postdoctoral training at the University of California, Los Angeles (UCLA).